Sarepta therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4)

Cambridge, mass.--(business wire)--sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, granted equity awards on october 31, 2023 that were previously approved by the compensation committee of its board of directors under sarepta's 2014 employment commencement incentive plan, as a material inducement to employment to 12 individuals hired by sarepta in october 2023. the equity awards were approved in accordance with nasdaq listing rule 5635(c)(4).
SRPT Ratings Summary
SRPT Quant Ranking